Listen "Moderna and Drug Discovery With AI"
Episode Synopsis
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a wide range of related topics, from the use of mRNA technology, to applying data for speeding up R&D for rare diseases. The discussion also touches on the deployment of generative AI across different parts of the Moderna platform tech stack.
More episodes of the podcast Tech Disruptors
AT&T Ventures Bets on Future Telecom Trends
29/12/2025
Amazon VP on Rufus and the Future of Search
17/12/2025
Workdays CTO on its Open-Platform Bet
09/12/2025
You.com CEO on Reinventing Search for AI Era
25/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.